| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |